Recent insights into the biological activities and drug delivery systems of tanshinones
- PMID: 26792989
- PMCID: PMC4708214
- DOI: 10.2147/IJN.S84035
Recent insights into the biological activities and drug delivery systems of tanshinones
Abstract
Tanshinones, the major lipid-soluble pharmacological constituents of the Chinese medicinal herb Tanshen (Salvia miltiorrhiza), have attracted growing scientific attention because of the prospective biomedical applications of these compounds. Numerous pharmacological activities, including anti-inflammatory, anticancer, and cardio-cerebrovascular protection activities, are exhibited by the three primary bioactive constituents among the tanshinones, ie, tanshinone I (TNI), tanshinone IIA (TNIIA), and cryptotanshinone (CPT). However, due to their poor solubility and low dissolution rate, the clinical applications of TNI, TNIIA, and CPT are limited. To solve these problems, many studies have focused on loading tanshinones into liposomes, nanoparticles, microemulsions, cyclodextrin inclusions, solid dispersions, and so on. In this review, we aim to offer an updated summary of the biological activities and drug delivery systems of tanshinones to provide a reference for these constituents in clinical applications.
Keywords: bioavailability; biological activities; drug delivery systems; solubility; tanshinones.
Figures
Similar articles
-
Tanshinones and their Derivatives: Heterocyclic Ring-Fused Diterpenes of Biological Interest.Mini Rev Med Chem. 2021;21(2):171-185. doi: 10.2174/1389557520666200429103225. Mini Rev Med Chem. 2021. PMID: 32348220 Review.
-
Comparative pharmacokinetics and tissue distribution of cryptotanshinone, tanshinone IIA, dihydrotanshinone I, and tanshinone I after oral administration of pure tanshinones and liposoluble extract of Salvia miltiorrhiza to rats.Biopharm Drug Dispos. 2020 Feb;41(1-2):54-63. doi: 10.1002/bdd.2213. Epub 2020 Jan 22. Biopharm Drug Dispos. 2020. PMID: 31943245
-
Reversal of P-glycoprotein (P-gp) mediated multidrug resistance in colon cancer cells by cryptotanshinone and dihydrotanshinone of Salvia miltiorrhiza.Phytomedicine. 2014 Sep 25;21(11):1264-72. doi: 10.1016/j.phymed.2014.06.013. Epub 2014 Jul 25. Phytomedicine. 2014. PMID: 25172788
-
Tanshinones from Chinese medicinal herb Danshen (Salvia miltiorrhiza Bunge) suppress prostate cancer growth and androgen receptor signaling.Pharm Res. 2012 Jun;29(6):1595-608. doi: 10.1007/s11095-012-0670-3. Epub 2012 Jan 27. Pharm Res. 2012. PMID: 22281759
-
Tanshinones: An Update in the Medicinal Chemistry in Recent 5 Years.Curr Med Chem. 2021;28(14):2807-2827. doi: 10.2174/0929867327666200521124850. Curr Med Chem. 2021. PMID: 32436817 Review.
Cited by
-
A Pharmacological Review of Tanshinones, Naturally Occurring Monomers from Salvia miltiorrhiza for the Treatment of Cardiovascular Diseases.Oxid Med Cell Longev. 2023 Feb 6;2023:3801908. doi: 10.1155/2023/3801908. eCollection 2023. Oxid Med Cell Longev. 2023. Retraction in: Oxid Med Cell Longev. 2024 Jan 9;2024:9808064. doi: 10.1155/2024/9808064. PMID: 36793978 Free PMC article. Retracted. Review.
-
Tanshinone IIA reduces oxidized low-density lipoprotein-induced inflammatory responses by downregulating microRNA-33 in THP-1 macrophages.Int J Clin Exp Pathol. 2019 Oct 1;12(10):3791-3798. eCollection 2019. Int J Clin Exp Pathol. 2019. PMID: 31933767 Free PMC article.
-
Sodium Tanshinone IIA Sulfonate Improves Hemodynamic Parameters, Cytokine Release, and Multi-Organ Damage in Endotoxemia Rabbits.Med Sci Monit. 2018 May 8;24:2975-2982. doi: 10.12659/MSM.909996. Med Sci Monit. 2018. PMID: 29735976 Free PMC article.
-
Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics.Acta Pharmacol Sin. 2018 May;39(5):802-824. doi: 10.1038/aps.2017.193. Epub 2018 Apr 26. Acta Pharmacol Sin. 2018. PMID: 29698387 Free PMC article. Review.
-
Perspectives of traditional herbal medicines in treating retinitis pigmentosa.Front Med (Lausanne). 2024 Dec 6;11:1468230. doi: 10.3389/fmed.2024.1468230. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39712182 Free PMC article.
References
-
- Zhou L, Zuo Z, Chow MS. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol. 2005;45(12):1345–1359. - PubMed
-
- Wang XH, Morris-Natschke SL, Lee KH. New developments in the chemistry and biology of the bioactive constituents of tanshen. Med Res Rev. 2007;27(1):133–148. - PubMed
-
- Cheng TO. Cardiovascular effects of Danshen. Int J Cardiol. 2007;121(1):9–22. - PubMed
-
- Xu S, Liu P. Tanshinone II-A: new perspectives for old remedies. Expert Opin Ther Pat. 2013;23(2):149–153. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources